The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis
about
Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.Assessment of a correlation between Canine Atopic Dermatitis Extent and Severity Index (CADESI-03) and selected biophysical skin measures (skin hydration, pH, and erythema intensity) in dogs with naturally occurring atopic dermatitis.Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells.On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramidesTherapeutic effects and immunomodulation of suanbo mineral water therapy in a murine model of atopic dermatitis.Effect of maternal ω3 fatty acid supplementation on infant allergy.Validation studies of outcome measures in pemphigus.Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models.Assessment of skin barrier function in podoconiosis: measurement of stratum corneum hydration and transepidermal water loss.CCR4+T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16.
P2860
Q27691377-2AA81567-7211-41B7-8407-567C10925824Q34109984-5841DB41-0663-48BD-B1D2-769BCFF25B75Q34388802-5C68A0BA-1C95-4DB5-9EC4-2FD3C69A1979Q35167249-072D3E19-BEF1-4798-BEDC-AF07DFE972F3Q35194480-D65CAEBD-DCA8-4C7B-AA07-6D7CA1B6AB97Q35568777-C0C12798-9609-4FF9-90A0-208EAF1E32AFQ36696383-6C2A5129-D756-40F8-9E07-0B7199EE0569Q37408388-13B6BD1D-7CE2-437E-83E7-4F9160282AD4Q37653941-BF0E7B1C-1B49-4BFF-A6CB-845261DC887BQ38793267-72CE5E26-D7F4-458D-BF1E-FCB622B464D0Q42687697-558AC6BA-C1A7-4FCB-A3DB-3E267EDCDBAFQ46760727-4B46F675-4B19-4AF7-AA64-3AED47E3D8F7Q50850403-3C3794ED-C86D-42B4-8497-7A259BB2CE64
P2860
The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The objective severity assessm ...... atients with atopic dermatitis
@ast
The objective severity assessm ...... atients with atopic dermatitis
@en
The objective severity assessm ...... atients with atopic dermatitis
@nl
type
label
The objective severity assessm ...... atients with atopic dermatitis
@ast
The objective severity assessm ...... atients with atopic dermatitis
@en
The objective severity assessm ...... atients with atopic dermatitis
@nl
prefLabel
The objective severity assessm ...... atients with atopic dermatitis
@ast
The objective severity assessm ...... atients with atopic dermatitis
@en
The objective severity assessm ...... atients with atopic dermatitis
@nl
P2093
P2860
P1476
The objective severity assessm ...... atients with atopic dermatitis
@en
P2093
I Angelova-Fischer
J Kazandjieva
M Williams
T Bruckner
P2860
P304
P356
10.1111/J.1365-2133.2005.06697.X
P407
P577
2005-10-01T00:00:00Z